Cytokinetics Stock Scores RS Rating Jump To 83

One important metric to look for in a stock is an 80 or higher Relative Strength Rating. Cytokinetics (CYTK) stock cleared that benchmark Monday, with a jump from 78 to 83 Monday. Â Hone Your Stock-Picking Skills By Focusing On These Factors IBD's proprietary RS Rating identifies market leadership by showing how a stock's price movement over the last 52… Related news Ginkgo Bioworks Holdings Stock Scores RS Rating Upgrade 9/29/2025Ginkgo Bioworks Holdings sees its Relative Strength Rating move into the elit ...